POS-692 Euglycemic Diabetic Ketoacidosis Related to SGLT2 Inhibitor Use in Kidney Transplant Patient with Squamous Cell Carcinoma

Autor: ALKINDI, F., Al Hakim, M., Chaaban, A., Boobes, Y.
Zdroj: In Kidney International Reports April 2021 6(4) Supplement:S302-S302
Databáze: ScienceDirect